A Extension Study of Udenafil in Adolescents



Status:Recruiting
Conditions:Cardiology
Therapuetic Areas:Cardiology / Vascular Diseases
Healthy:No
Age Range:12 - 18
Updated:1/19/2019
Start Date:January 2017
End Date:December 2019
Contact:Steve Paridon, MD
Email:paridon@email.chop.edu
Phone:2155903532

Use our guide to learn which trials are right for you!

A Phase III Extension Study of Udenafil in Adolescents With Single Ventricle Physiology After Fontan Palliation

This study is a 12-month (52 week) safety extension study to supplement the FUEL Phase III
clinical trial to provide safety information regarding the long-term use of udenafil in
adolescents with single ventricle congenital heart disease.

This will be an open-label extension study. All enrolled subjects will be provided with
udenafil for the duration of the study. Subjects completing the Phase III FUEL study will be
eligible for recruitment. Additional subjects will be recruited as needed to ensure a minimum
of 300 total subjects enroll. Safety, pharmacodynamic and quality of life data will be
collected and analyzed.

Inclusion Criteria:

1. Males and females with Fontan physiology who participated in the FUEL trial or, if
they did not participate in FUEL, those who are 12 to less than 19 years of age at
enrollment.

2. Participant consent or parental/guardian consent and participant assent.

3. Participant fluent in English, Spanish, or Korean.

4. Current anti-platelet or anticoagulant therapy.

Exclusion Criteria:

1. Height < 132 cm.

2. Weight < 40 kg.

3. Hospitalization for acute decompensated heart failure within the last 12 months.

4. Current intravenous inotropic drugs.

5. Undergoing evaluation for heart transplantation or listed for transplantation.

6. Diagnosis of active protein losing enteropathy or plastic bronchitis within the last
three years, or a history of liver cirrhosis.

7. Known Fontan baffle obstruction, branch pulmonary artery stenosis, or pulmonary vein
stenosis resulting in a mean gradient of > 4 mm Hg between the regions proximal and
distal to the obstruction as measured by either catheterization or echocardiography.

8. Single lung physiology.

9. Maximal VO2 less than 50% of predicted for age and gender at enrollment.

10. Severe ventricular dysfunction assessed qualitatively by clinical echocardiography
within six months prior to enrollment.

11. Severe valvar regurgitation, ventricular outflow obstruction, or aortic arch
obstruction assessed by clinical echocardiography within six months prior to
enrollment.

12. Significant renal, hepatic, gastrointestinal or biliary disorders that could impair
absorption, metabolism or excretion of orally administered medications.

13. Inability to complete exercise testing at baseline screening.

14. History of PDE-5 inhibitor use (with the exception of FUEL participation) within 3
months before study onset.

15. Use of any other drug to treat pulmonary hypertension within 3 months before study
onset.

16. Known intolerance to oral udenafil.

17. Frequent use of medications or other substances that inhibit or induce CYP3A4.

18. Current use of alpha-blockers or nitrates.

19. Ongoing or planned participation in another research protocol that would either
prevent successful completion of planned study testing or invalidate its results.

20. Noncardiac medical, psychiatric, and/or social disorder that would prevent successful
completion of planned study testing or would invalidate its results.

21. Cardiac care, ongoing or planned, at a non-study center that would impede study
completion.

22. For females: Pregnancy at the time of screening, pregnancy planned before study
completion, or refusal to use an acceptable method of contraception for study
duration.

23. Unable to abstain or limit intake of grapefruit juice during the duration of the
trial.

24. Refusal to provide written informed consent/assent.

25. In the opinion of the primary care physician, the subject is likely to be
non-compliant with the study protocol.

26. History of clinically significant thromboembolic event, as adjudicated by study
Investigators.
We found this trial at
22
sites
555 University Avenue
Toronto, Ontario M5G 1X8
Principal Investigator: Seema Mital, MD
Phone: 4168137654
?
mi
from
Toronto,
Click here to add this to my saved trials
3333 Burnet Avenue # Mlc3008
Cincinnati, Ohio 45229
 1-513-636-4200 
Principal Investigator: Bryan H Goldstein, MD
Phone: 513-636-7072
Cincinnati Children's Hospital Medical Center Patients and families from across the region and around the...
?
mi
from
Cincinnati, OH
Click here to add this to my saved trials
South 34th Street
Philadelphia, Pennsylvania 19104
 215-590-1000
Principal Investigator: David Goldberg, MD
Phone: 267-426-8143
Children's Hospital of Philadelphia Since its start in 1855 as the nation's first hospital devoted...
?
mi
from
Philadelphia, PA
Click here to add this to my saved trials
Ann Arbor, Michigan 48109
Principal Investigator: Kurt R Schumacher, MD
Phone: 734-764-5176
?
mi
from
Ann Arbor, MI
Click here to add this to my saved trials
1405 Clifton Road NE
Atlanta, Georgia 30322
404-785-6000
Principal Investigator: Christopher Petit, MD
Phone: 404-785-1796
Children's Healthcare of Atlanta Whether treating a toddler in an emergency or supporting a teen...
?
mi
from
Atlanta, GA
Click here to add this to my saved trials
13123 E 16th Ave
Aurora, Colorado 80045
(720) 777-1234
Principal Investigator: Michael V DiMaria, MD
Phone: 720-777-4420
Children's Hospital Colorado At Children's Hospital Colorado, we see more, treat more and heal more...
?
mi
from
Aurora, CO
Click here to add this to my saved trials
300 Longwood Ave
Boston, Massachusetts 02115
(617) 355-6000
Principal Investigator: Jonathan Rhodes, MD
Phone: 617-355-3491
Boston Children's Hospital Boston Children's Hospital is a 395-bed comprehensive center for pediatric health care....
?
mi
from
Boston, MA
Click here to add this to my saved trials
171 Ashley Avenue
Charleston, South Carolina 29425
843-792-1414
Principal Investigator: Andrew M Atz, MD
Phone: 843-792-3292
Medical University of South Carolina The Medical University of South Carolina (MUSC) has grown from...
?
mi
from
Charleston, SC
Click here to add this to my saved trials
6621 Fannin St
Houston, Texas 77030
(832) 824-1000
Principal Investigator: Daniel Penny, MD, PhD
Phone: 832-826-1997
Texas Children's Hospital Texas Children's Hospital, located in Houston, Texas, is a not-for-profit organization whose...
?
mi
from
Houston, TX
Click here to add this to my saved trials
Indianapolis, Indiana 46201
Principal Investigator: Mark Payne, MD
Phone: 317-278-6239
?
mi
from
Indianapolis, IN
Click here to add this to my saved trials
Kansas City, Missouri 64108
Principal Investigator: Girish Shirali, MD
Phone: 816-234-3947
?
mi
from
Kansas City, MO
Click here to add this to my saved trials
Los Angeles, California 90048
Principal Investigator: Ruchira Garg, MD
Phone: 310-423-1153
?
mi
from
Los Angeles, CA
Click here to add this to my saved trials
9000 W Wisconsin Ave #270
Milwaukee, Wisconsin 53226
(414) 266-2000
Principal Investigator: Salil Grinde, MD
Phone: 708-204-2963
Children's Hospital of Wisconsin Nothing matters more than our children. At Children's Hospital of Wisconsin,...
?
mi
from
Milwaukee, WI
Click here to add this to my saved trials
New York, New York 10032
Principal Investigator: Marc Richmond, MD
Phone: 212-305-6575
?
mi
from
New York, NY
Click here to add this to my saved trials
Phoenix, Arizona 85016
Principal Investigator: Tabitha G Moe, MD
Phone: 602-933-3366
?
mi
from
Phoenix, AZ
Click here to add this to my saved trials
660 South Euclid Avenue
Saint Louis, Missouri 63110
Principal Investigator: Charles Canter, MD
Phone: 314-454-6095
?
mi
from
Saint Louis, MO
Click here to add this to my saved trials
501 6th Avenue South
Saint Petersburg, Florida 33701
Principal Investigator: Jeffrey Jacobs, MD
Phone: 727-767-6666
?
mi
from
Saint Petersburg, FL
Click here to add this to my saved trials
Salt Lake City, Utah 84113
Principal Investigator: Shaji C Menon, MD
Phone: 801-662-5400
?
mi
from
Salt Lake City, UT
Click here to add this to my saved trials
San Diego, California 92123
Principal Investigator: Christopher Davis, MD, PhD
Phone: 858-966-5855
?
mi
from
San Diego, CA
Click here to add this to my saved trials
Seattle, Washington 98105
Principal Investigator: Matthew Files, MD
Phone: 206-987-1787
?
mi
from
Seattle, WA
Click here to add this to my saved trials
111 Michigan Ave NW
Washington, District of Columbia
(202) 476-5000
Principal Investigator: Anitha John, MD. PhD
Phone: 202-476-2728
Childrens National Medical Center As the nation’s children’s hospital, the mission of Children’s National Medical...
?
mi
from
Washington,
Click here to add this to my saved trials
Wilmington, Delaware 19803
Principal Investigator: Amanda Shillingford, MD
Phone: 302-651-6600
?
mi
from
Wilmington, DE
Click here to add this to my saved trials